IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Allogene Therapeutics, Inc.

CUSIP: 000173728 | 1 institutional holders

Quarters

Q2 2019Q1 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2019

Private Capital Advisors, Inc.10,000
0.0% of portfolio›$268
StyleTurnoverLocationFiled
Private Capital Advisors, Inc.
10,000$2680.0%Agg GrowthLowDarien, CT2019-07-18